Genstar purchases ERT for $400M; Poland shows 'moderate' growth in clinical trials;

 @NesaNFierce: Argentina is becoming more than the birthplace of Tango, growing in terms of outsourcing. More | Follow @NesaNFierce

> Ampio Pharmaceuticals has selected CRMO Syngene to conduct clinical trials on its three lead drugs to treat premature ejaculation and erectile dysfunction. Release

> Poland, a country that has been seen as a growing site for outsourcing, has showed moderate growth in its clinical trials market, according to a PMR report. More

> Private equity firm Genstar Capital has completed its take-private acquisition of ERT for approximately $400 million. Story

> CDMO Encap has announced it will invest $2 million in new filling equipment to boost its manufacturing services. Release

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

While the biotech IPO market booms, it can look like going public is easy. But the right strategy, syndicate and aftermarket are still important.

Signant Health is ramping up its virtual trial model after buying VirTrial to “truly digitize the operations of clinical study sites.”

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.